See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $51.1B | 3.0x | 10.2x | |
| $3.3B | n/a | n/a | |
| $3.2B | 6.2x | 17.9x | |
| $2.6B | 9.7x | -31.8x | |
| $2.4B | 2.9x | 14.5x | |
| $2.4B | 32.0x | -17.9x | |
| $2.1B | 0.9x | 6.3x | |
| $2.1B | 85.3x | n/a | |
| $1.9B | 6.6x | 13.9x | |
| $1.8B | 7.4x | 21.4x | |
| $1.6B | 7.2x | 28.6x | |
| $1.5B | 11.0x | -36.7x | |
| $1.5B | 8.8x | 86.9x | |
| $1.3B | 6.3x | n/a | |
| $1.1B | 8.8x | 20.3x | |
| $813M | n/a | n/a | |
| $747M | 5.9x | n/a | |
| $740M | 6.4x | 36.3x | |
| $738M | n/a | -27.8x | |
| $730M | 18.7x | -11.7x | |
| $681M | 3.1x | 22.7x | |
| $644M | 29.4x | n/a | |
| $633M | 7.2x | 20.8x | |
| $607M | 2.1x | 4.9x | |
| $494M | n/a | -6.0x | |
| $361M | 42.2x | n/a | |
| $321M | 184.3x | -78.0x | |
| $256M | 2.4x | 104.9x | |
| $184M | n/a | -6.6x | |
| $153M | 6.2x | -6.7x | |
| $143M | n/a | n/a | |
| $117M | 0.4x | 3.9x | |
| $79.6M | 7.5x | n/a | |
| $77.9M | 4.5x | n/a | |
| $74.1M | 2.4x | n/a | |
| $59.9M | n/a | -0.7x | |
| $30.3M | 0.4x | 1.7x | |
| $7.7M | 20.7x | n/a | |
| -$53.3M | n/a | 0.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules